HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 84,
"next": "http://api.gregory-ms.com/trials/source/12/?format=api&page=6",
"previous": "http://api.gregory-ms.com/trials/source/12/?format=api&page=4",
"results": [
{
"title": "Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.",
"summary": "<b>Conditions</b>: Radiologically Isolated Syndrome; Multiple Sclerosis\n<br /><b>Interventions</b>: Other: Observational\n<br /><b>Sponsors</b>: Centre Hospitalier Universitaire de Nīmes; International Center of Research in Infectiology, Lyon University; Universite Cote d'Azur; The University of Texas at Dallas\n<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/study/NCT06395662?cond=Multiple+Sclerosis",
"published_date": "2024-05-02T04:00:00Z",
"sources": [],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2024-05-09T18:58:57.214674Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Blood Flow Restriction Training in Multiple Sclerosis",
"summary": "<b>Conditions</b>: MS\n<br /><b>Interventions</b>: Other: strengthening ex with BFR training; Other: strengthening ex\n<br /><b>Sponsors</b>: Cairo University\n<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/study/NCT06143930?cond=Multiple+Sclerosis",
"published_date": "2023-11-22T05:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2023-11-22T13:43:10.591844Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "ALS Phase II Study of NX210c",
"summary": "<b>Conditions</b>: Amyotrophic Lateral Sclerosis\n<br /><b>Interventions</b>: Drug: NX210c; Drug: Placebo\n<br /><b>Sponsors</b>: Axoltis Pharma; ACT4ALS network\n<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/study/NCT06365216?cond=Multiple+Sclerosis",
"published_date": "2024-04-15T04:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2024-04-26T04:25:56.792827Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)",
"summary": "Condition: SARS-CoV InfectionInterventions: Biological: COMIRNATY - BioNTech Manufacturing GmbH; Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH; Biological: COVID-19 Vaccine AstraZeneca suspension for injectionSponsors : Jens D Lundgren, MD; Ministry of the Interior and Health, DenmarkRecruiting ",
"link": "https://clinicaltrials.gov/ct2/show/NCT04760132?term=biontech&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-02-18T17:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2021-02-27T01:00:00Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older",
"summary": "Conditions: SARS-CoV-2 Infection; COVID-19; Maternal ImmunizationInterventions: Biological: BNT162b2; Other: PlaceboSponsors : BioNTech SE; PfizerNot yet recruiting ",
"link": "https://clinicaltrials.gov/ct2/show/NCT04754594?term=biontech&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-02-15T17:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2021-02-27T01:00:00Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Antibody Response to COVID-19 Vaccines in Liver Disease Patients",
"summary": "Condition: Chronic Liver DiseaseInterventions: Biological: BNT162b2; Biological: CoronaVac; Biological: AZD1222Sponsor : Humanity & Health Medical Group LimitedNot yet recruiting ",
"link": "https://clinicaltrials.gov/ct2/show/NCT04775069?term=biontech&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-03-01T17:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2021-01-03T01:00:00Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis",
"summary": "Conditions: Multiple Sclerosis; Covid19Intervention: Sponsor : St. Barnabas Medical CenterRecruiting ",
"link": "https://clinicaltrials.gov/ct2/show/NCT04834401?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-04-07T16:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2021-04-08T11:57:29Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis",
"summary": "Condition: Multiple SclerosisInterventions: Other: Technology Supported Task-Oriented Circuit Training; Other: Home-based TelerehabilitationSponsor : Hacettepe UniversityActive, not recruiting ",
"link": "https://clinicaltrials.gov/ct2/show/NCT04891341?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-05-18T16:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2021-05-18T10:30:26Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research",
"summary": "Condition: Estimate the Number of Spinal Cord Lesions Detected With the 3D FGAPSIR Sequence That Were Not Detected With the 3D PSIR SequenceIntervention: Device: MRISponsor : Fondation Ophtalmologique Adolphe de RothschildEnrolling by invitation ",
"link": "https://clinicaltrials.gov/ct2/show/NCT04906928?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-05-28T16:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2021-05-28T12:44:08Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "The Reliability of the Nine Hole Peg Test in Patients With Multiple Sclerosis",
"summary": "Condition: Motor ActivityIntervention: Diagnostic Test: Nine Hole Peg TestSponsor : Charles University, Czech RepublicNot yet recruiting ",
"link": "https://clinicaltrials.gov/ct2/show/NCT05012241?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2021-08-19T16:00:00Z",
"sources": [
"Clinical Trials.gov"
],
"teams": [
{
"id": 1,
"name": "Team Gregory"
}
],
"subjects": [
{
"subject_name": "Multiple Sclerosis",
"description": null
}
],
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"ml_prediction_lsvc": null,
"discovery_date": "2021-08-19T15:05:47Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
}
]
}